Progenerative Medical (PGM) and Johnson & Johnson Medical Devices Companies Center for Device Innovation at Texas Medical Center (CDI @ TMC) have agreed to explore new orthopedic applications based on PGM’s extensive intellectual property portfolio for reduced pressure therapy.  The agreement brings engineering teams and resources from both companies together to collaborate on ideation, prototyping, and testing of new surgical applications, as well as residency at CDI @ TMC’s state-of-the-art facility in Houston.  “We are looking forward to working with CDI @ TMC with the aim to develop new technologies designed for the orthopedic surgical market” said Neal Vail, PhD, Co-Founder and CTO of Progenerative.  “This collaboration can allow us to accelerate our pipeline development efforts with one of the top medical device companies in the orthopedic market”.